Ablynx Nv(ABLX)

nomage2021-04-20 10:58

回复@凯雷Soros: 你坏的很呐，18年ablynx 就值39亿美金，而且它哪个产品推进的比康宁快？比康宁慢的多。管线数量十倍更是胡说八道，它只是有40个筛选物，推进到临床的管线价值可能还不如康宁。而且39亿美金可是美股18年定价。18年药明系整个放在美股不知道值不值39亿。//@凯雷Soros:回复@小火慢炖0...查看全文

凯雷Soros2021-04-20 10:51

回复@小火慢炖008: KN35毒副作用还是存在，只是NMPA那边出于鼓励创新，可能会睁只眼闭只眼，FDA有较大概率通不过。之前做Fc融合方案的单域抗体，无论是诺华TAS266还是Ablynx的ALX651都是因毒副作用太大终止了。要论估值低，单域抗体的老大Ablynx无论管线数量（十倍于康宁）和技术（领先康宁五年）...查看全文

H3llinger2018-03-26 16:36

$Ablynx NV - American Depositary Shares(ABLX)$ said Monday that the Phase II dose-ranging study of vobarilizumab, the Company's anti-IL-6R Nanobody, did not meet the primary endpoint of dose response based on the modified BILAG-based combined lupus assessment or mBICLA at...查看全文

赛诺菲携手Alnylam，罕见病新药获得FDA突破性疗法认定

药渡2018-03-13 21:58

近日有消息称，法国制药巨头Sanofi与致力于RNAi疗法的Alnylam在完成对两款RNAi药物Patisiran和Fitusiran的交易重组后，正打算联手推进处于开发后期的罕见病新药Lumasiran，用于治疗原发性高草酸尿症I型，近日获得FDA授予的突破性疗法认定。
原发性高草酸尿症I型是一种罕见疾病，由过量的草酸...查看全文

淘沙见金2018-01-29 21:26

比起现在的 $Armo Biosciences, Inc.(ARMO)$ 和 $Menlo Therapeutics, Inc.(MNLO)$ 开盘即暴涨， $Ablynx NV - American Depositary Shares(ABLX)$ 当时IPO真是良心价。定价17，开盘17.5。Novo在并购上步子迈的实在太慢，错过KITE，这次又被Sanofi抢了。Novo下一个收购哪个公司呢？GBT-药物略有风...查看全文

张小丰2018-01-29 17:45

$Ablynx NV - American Depositary Shares(ABLX)$ 赛诺菲横刀夺爱。。收购了ABLX。
今年减税以后生物科技的收购已经疯了。。才1个月已经来了4个收购。其中3个都是大型收购。查看全文

Pharmayang2018-01-23 11:43

$Ablynx NV - American Depositary Shares(ABLX)$ 公司不错，那个抗血凝药算罕见病，效果很好批准应该没问题。其他的pipelines也很强，很多IO的合作。novo是很靠谱的大公司，他看上的估计就算最后他不买，其它公司也会买。买点屯着。查看全文

淘沙见金2018-01-08 21:12

$Ablynx NV - American Depositary Shares(ABLX)$ NVO $3.1B bids for ABLX. 从IPO拿到现在已经翻倍，希望这周有更多的deal会公布。查看全文

will19682017-10-26 00:09

$Ablynx NV(ABLX)$ 涨的好呀查看全文

$Ablynx NV - American Depositary Shares(ABLX)$ SC14D9C - Written communication relating to third party tender offer Filed: 2018-01-29 AccNo: 0001193125-18-022513 Size: 15 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-01-29 AccNo: 0001193125-18-022434 Size: 56 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ SC14D9C - Written communication relating to third party tender offer Filed: 2018-01-29 AccNo: 0001193125-18-022513 Size: 15 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-01-29 AccNo: 0001193125-18-022434 Size: 56 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-01-23 AccNo: 0001104659-18-003608 Size: 596 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-01-23 AccNo: 0001104659-18-003608 Size: 596 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-01-09 AccNo: 0001193125-18-006213 Size: 31 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-12-21 AccNo: 0001193125-17-376453 Size: 33 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-12-12 AccNo: 0001193125-17-367484 Size: 38 KB 网页链接

$Ablynx NV - American Depositary Shares(ABLX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-12-07 AccNo: 0001193125-17-363863 Size: 32 KB 网页链接